Annual EBITDA
-$163.12 M
+$56.50 M+25.73%
31 December 2023
Summary:
Editas Medicine annual earnings before interest, taxes, depreciation & amortization is currently -$163.12 million, with the most recent change of +$56.50 million (+25.73%) on 31 December 2023. During the last 3 years, it has fallen by -$32.24 million (-24.63%). EDIT annual EBITDA is now -1108.81% below its all-time high of -$13.49 million, reached on 31 December 2014.EDIT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$64.07 M
+$6.42 M+9.10%
30 September 2024
Summary:
Editas Medicine quarterly earnings before interest, taxes, depreciation & amortization is currently -$64.07 million, with the most recent change of +$6.42 million (+9.10%) on 30 September 2024. Over the past year, it has dropped by -$15.42 million (-31.69%). EDIT quarterly EBITDA is now -734.58% below its all-time high of $10.10 million, reached on 30 September 2020.EDIT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$222.63 M
-$15.42 M-7.44%
30 September 2024
Summary:
Editas Medicine TTM earnings before interest, taxes, depreciation & amortization is currently -$222.63 million, with the most recent change of -$15.42 million (-7.44%) on 30 September 2024. Over the past year, it has dropped by -$20.14 million (-9.95%). EDIT TTM EBITDA is now -4077.67% below its all-time high of -$5.33 million, reached on 31 December 2014.EDIT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EDIT EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.7% | -31.7% | -9.9% |
| 3 y3 years | -24.6% | -68.3% | -4.7% |
| 5 y5 years | -47.6% | -89.2% | -78.3% |
EDIT EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -24.6% | +25.7% | -184.8% | +9.1% | -36.5% | at low |
| 5 y | 5 years | -47.6% | +25.7% | -734.6% | +9.1% | -112.4% | at low |
| alltime | all time | -1108.8% | +25.7% | -734.6% | +9.1% | -4077.7% | at low |
Editas Medicine EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$64.07 M(-9.1%) | -$222.63 M(+7.4%) |
| June 2024 | - | -$70.48 M(+7.5%) | -$207.21 M(+15.6%) |
| Mar 2024 | - | -$65.58 M(+191.5%) | -$179.28 M(+9.9%) |
| Dec 2023 | -$163.12 M(-25.7%) | -$22.50 M(-53.8%) | -$163.12 M(-19.4%) |
| Sept 2023 | - | -$48.65 M(+14.3%) | -$202.49 M(-3.5%) |
| June 2023 | - | -$42.55 M(-13.9%) | -$209.76 M(-4.6%) |
| Mar 2023 | - | -$49.42 M(-20.1%) | -$219.84 M(+0.1%) |
| Dec 2022 | -$219.61 M(+16.8%) | -$61.87 M(+10.6%) | -$219.61 M(+11.0%) |
| Sept 2022 | - | -$55.92 M(+6.2%) | -$197.84 M(+9.9%) |
| June 2022 | - | -$52.64 M(+7.0%) | -$179.99 M(-0.9%) |
| Mar 2022 | - | -$49.19 M(+22.7%) | -$181.57 M(-3.5%) |
| Dec 2021 | -$188.09 M(+43.7%) | -$40.10 M(+5.3%) | -$188.09 M(-11.6%) |
| Sept 2021 | - | -$38.06 M(-29.8%) | -$212.68 M(+29.3%) |
| June 2021 | - | -$54.21 M(-2.7%) | -$164.53 M(+16.9%) |
| Mar 2021 | - | -$55.72 M(-13.9%) | -$140.78 M(+7.6%) |
| Dec 2020 | -$130.88 M(-5.2%) | -$64.69 M(-740.7%) | -$130.88 M(+24.8%) |
| Sept 2020 | - | $10.10 M(-133.1%) | -$104.83 M(-29.5%) |
| June 2020 | - | -$30.47 M(-33.5%) | -$148.79 M(-2.9%) |
| Mar 2020 | - | -$45.82 M(+18.6%) | -$153.28 M(+11.0%) |
| Dec 2019 | -$138.09 M | -$38.64 M(+14.1%) | -$138.09 M(+10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$33.86 M(-3.1%) | -$124.82 M(+17.3%) |
| June 2019 | - | -$34.96 M(+14.1%) | -$106.38 M(-3.6%) |
| Mar 2019 | - | -$30.63 M(+20.7%) | -$110.30 M(-0.2%) |
| Dec 2018 | -$110.47 M(-5.3%) | -$25.37 M(+64.6%) | -$110.47 M(-8.1%) |
| Sept 2018 | - | -$15.42 M(-60.3%) | -$120.24 M(-8.1%) |
| June 2018 | - | -$38.87 M(+26.2%) | -$130.88 M(+11.4%) |
| Mar 2018 | - | -$30.81 M(-12.3%) | -$117.47 M(+0.7%) |
| Dec 2017 | -$116.66 M(+21.5%) | -$35.14 M(+34.8%) | -$116.66 M(-2.8%) |
| Sept 2017 | - | -$26.07 M(+2.4%) | -$120.08 M(+4.5%) |
| June 2017 | - | -$25.46 M(-15.1%) | -$114.90 M(+6.0%) |
| Mar 2017 | - | -$30.00 M(-22.2%) | -$108.39 M(+12.9%) |
| Dec 2016 | -$96.04 M(+32.9%) | -$38.55 M(+84.6%) | -$96.04 M(-10.4%) |
| Sept 2016 | - | -$20.88 M(+10.2%) | -$107.16 M(+14.6%) |
| June 2016 | - | -$18.95 M(+7.4%) | -$93.53 M(+10.2%) |
| Mar 2016 | - | -$17.65 M(-64.5%) | -$84.86 M(+17.2%) |
| Dec 2015 | -$72.29 M(+435.7%) | -$49.67 M(+585.1%) | -$72.39 M(+158.1%) |
| Sept 2015 | - | -$7.25 M(-29.5%) | -$28.04 M(+34.9%) |
| June 2015 | - | -$10.29 M(+98.7%) | -$20.79 M(+97.9%) |
| Mar 2015 | - | -$5.18 M(-2.9%) | -$10.51 M(+97.1%) |
| Dec 2014 | -$13.49 M | -$5.33 M | -$5.33 M |
FAQ
- What is Editas Medicine annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Editas Medicine?
- What is Editas Medicine annual EBITDA year-on-year change?
- What is Editas Medicine quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Editas Medicine?
- What is Editas Medicine quarterly EBITDA year-on-year change?
- What is Editas Medicine TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Editas Medicine?
- What is Editas Medicine TTM EBITDA year-on-year change?
What is Editas Medicine annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of EDIT is -$163.12 M
What is the all time high annual EBITDA for Editas Medicine?
Editas Medicine all-time high annual earnings before interest, taxes, depreciation & amortization is -$13.49 M
What is Editas Medicine annual EBITDA year-on-year change?
Over the past year, EDIT annual earnings before interest, taxes, depreciation & amortization has changed by +$56.50 M (+25.73%)
What is Editas Medicine quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of EDIT is -$64.07 M
What is the all time high quarterly EBITDA for Editas Medicine?
Editas Medicine all-time high quarterly earnings before interest, taxes, depreciation & amortization is $10.10 M
What is Editas Medicine quarterly EBITDA year-on-year change?
Over the past year, EDIT quarterly earnings before interest, taxes, depreciation & amortization has changed by -$15.42 M (-31.69%)
What is Editas Medicine TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of EDIT is -$222.63 M
What is the all time high TTM EBITDA for Editas Medicine?
Editas Medicine all-time high TTM earnings before interest, taxes, depreciation & amortization is -$5.33 M
What is Editas Medicine TTM EBITDA year-on-year change?
Over the past year, EDIT TTM earnings before interest, taxes, depreciation & amortization has changed by -$20.14 M (-9.95%)